表紙
市場調查報告書
商品編碼
1063526

生物科技的全球市場:調查檢討 (2021年)

2021 Biotechnology Research Review

出版日期: | 出版商: BCC Research | 英文 312 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球生物科技市場整體的趨勢相關分析,以BCC Research 2021年出版的生物科技市場相關12個市場調查報告的概要為套組,為您概述為以下內容。

目錄

第1章 序文

第2章 胞外體診斷及治療的全球市場 (BIO149D)

第3章 生物資訊學:科技和全球市場 (BIO051F)

第4章 細胞、基因治療的全球市場 (BIO225A)

第5章 次世代定序:新的臨床應用和全球市場 (BIO126D)

第6章 生命科學工具和試劑的全球市場 (BIO083D)

第7章 DNA定序的全球市場:研究、應用、臨床市場 (BIO045H)

第8章 全球mRNA治療市場 (BIO212A)

第9章 癌症幹細胞:技術和全球市場 (BIO158B)

第10章 研究用抗體的全球市場 (BIO141C)

第11章 液態切片的研究工具、服務、診斷的全球市場 (BIO150D)

第12章 誘導性多功能幹細胞:全球市場 (BIO135D)

第13章 細胞治療生物製造業:全球市場 (BIO211A)

目錄
Product Code: BIO069J

Highlights:

The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.

The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.

The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.

Report Highlights:

  • The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
  • The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
  • The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.

There have been a number of significant developments that has accelerated growth across the biotechnology market. These notable recent advancements include, mRNA therapeutics, CRISPR technology, biosensors and bioprinting technologies, cancer stem cell research, alongside cell and gene therapy and DNA vaccines. These advancements ensure the wide adoption of cell line technologies that support drug development and the simplification of the gene editing process, making it more cost effective long-term.

Advancement in molecular biology is supporting the delivery of molecular and computational tools and software. Synthetic biology is another field of application that promotes the manufacturing of and/or modification of genetic material in living cells.

Unlike other industries, the biotech industry has witnessed high growth throughout the pandemic. The search for diagnostic treatment methods for COVID-19 has forced governments, the media and the general public alike to focus on science and medicine, strengthening the idea that biotech acquisitions and partnerships are solid investments. Companies operating in the cell line market are now investing large amounts, enabling the development of manufacturing units with advanced, state of the art resources and expanded facilities. At the same time, genetic sequencing technology is advancing at a great pace, especially across the healthcare sector in the diagnosis of various cancers and strains of Coronavirus.

In 2019 and 2020, the biotech industry saw double digit annual growth due to fundraising from venture capitals, partnerships, co-development and joint ventures. However, the sector does continuous challenging relating to marketing, funding for innovation and pricing pressures from government organizations. Development costs are also a challenge, and often the most critical for manufacturers. While a simple cholesterol drug may cost $5 per day (approximately $1,825 per annum), a biotech drug may cost around $20,000 or more a year.

In 2019, gene therapy and cell biology technologies were successfully developed, however, this came at a high cost. For example, Zolgensma, a viral vector-based gene therapy for the treatment of spinal muscular atrophy costs around $5 million. It is important for manufacturers to figure out how to balance the cost of innovation that proves most challenging. Getting the pricing right, and the costs involved with getting the products to market are also vital challenges. Innovation may take several years to move from a clinical trial phase to market launch, and investors may face disappointment and falling stock if expectations are not managed from the offset.

This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2021 on the following biotech markets -

  • BIO149D Exosome Diagnostics and Therapeutics: Global Markets
  • BIO051F Bioinformatics: Technologies and Global Markets
  • BIO225A Global Cell and Gene Therapy Market
  • BIO126D Next-generation Sequencing: Emerging Clinical Applications and Global Markets
  • BIO083D Life Science Tools and Reagents: Global Markets
  • BIO045H Global DNA Sequencing: Research, Applied and Clinical Markets
  • BIO212A mRNA: Therapeutics and Global Markets
  • BIO158B Cancer Stem Cells: Technologies and Global Markets
  • BIO150D Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
  • BIO135D Induced Pluripotent Stem Cells: Global Markets
  • BIO141C Global Markets for Research Antibodies
  • BIO211A Cell Therapy Biomanufacturing: Global Markets

We hope you find this Research Review valuable. We encourage you to obtain and benefit from the full market research reports that are excerpted in this Research Review. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

  • Foreword

Chapter 2 Exosome Diagnostics and Therapeutics: Global Markets (BIO149D)

  • Introduction
  • Study Goals and Objectives
  • Scope of Report
  • Information Sources
  • Intended Audience
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Overview
  • Exosome Definition and Nomenclature
  • Exosome Components
  • Exosome and COVID-19 Treatment
  • Exosome Diagnostic Market
  • Exosome Therapeutic Market
  • Market Breakdown by End User
  • Market Breakdown by Region
  • Patent Analysis
  • U.S. Patent Analysis
  • European Patent Analysis
  • Pipeline Analysis

Chapter 3 Bioinformatics: Technologies and Global Markets (BIO051F)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Research Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Trends
  • Market Breakdown
  • Global Market for Bioinformatics by Sequencing Services and Platforms
  • Global Market for Bioinformatics by Solution
  • Global Market for Bioinformatics by End User
  • Global Market for Bioinformatics by Region
  • Bioinformatics Applications in Pharmaceutical R&D
  • Drug Discovery and Development Process
  • Clinical Research: Drug Development
  • Post-Launch Ongoing Studies and Phase IV Clinical Trials
  • Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
  • Conclusions

Chapter 4 Global Cell and Gene Therapy Market (BIO225A)

  • Introduction
  • Study Goals and Objectives
  • Scope of This Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Highlights of the Market for Cell and Gene Therapy
  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Market Breakdown by Product
  • Market Breakdown by Application
  • Market Breakdown by Region
  • Pipeline Analysis
  • Drugs Pending Approval
  • Competitive Landscape: Overview
  • Market Share Analysis
  • Strategic Acquisitions and Collaborations

Chapter 5 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126D)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports
  • Summary and Highlights
  • Next-generation Sequencing and Markets
  • Clinical NGS Testing Market
  • Growth Drivers of Clinical NGS
  • Key Trends
  • Industry
  • Sequencing Technologies
  • History of DNA Sequencing
  • Clinical NGS Markets
  • Market Dynamics
  • Clinical NGS Market by Disease Category
  • Clinical NGS Market by Complexity
  • Clinical NGS Market by Test Purpose
  • Geographical Markets

Chapter 6 Life Science Tools and Reagents: Global Markets (BIO083D)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Dynamics
  • Market Drivers
  • Market Restraints and Challenges
  • Market Opportunities
  • Global Market for Life Science Tools and Reagents, by End-User Application
  • Global Market for Life Science Tools and Diagnostics, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045H)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Analyst's Credentials
  • Related BCC Research Reports
  • Summary and Highlights
  • Overview
  • Sequencing Growth Driving Forces
  • Research and Applied Applications
  • Clinical Applications
  • Market for DNA Sequencing
  • Market Breakdown by Major Segment
  • Geographical Markets

Chapter 8 mRNA: Therapeutics and Global Markets (BIO212A)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Situation for RNA Therapeutics
  • Well-Developed Markets
  • Developing Markets
  • Underdeveloped Markets
  • mRNA Vaccines
  • Clinical Need for mRNA Vaccines
  • mRNA Vaccines and Types by Application
  • Marketed/Commercial mRNA Vaccines
  • mRNA Vaccines: New Developments
  • mRNA Vaccines and Future Pandemics
  • mRNA Drugs and Therapies
  • Clinical Need for mRNA Therapeutics Beyond Vaccines
  • mRNA as Gene and Protein Replacement Therapy
  • mRNA-Enhanced Cell Therapies
  • mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
  • mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
  • mRNA Therapeutics and New Developments
  • Market Size and Growth Analysis by Product Segment
  • Market Size and Growth Analysis by Therapeutic Application
  • Market Size and Growth Analysis by Disease Type
  • SWOT Analysis of the Market for mRNA Therapeutics

Chapter 9 Cancer Stem Cells: Technologies and Global Markets (BIO158B)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources & Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
  • Market Breakdown by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Chapter 10 Global Markets for Research Antibodies (BIO141C)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Trends in the Market for Research Antibodies
  • Purchasing Factors Analysis
  • Third-Party Quality Evaluation Systems
  • Research Grants
  • Global Market for Research Antibodies by Product
  • Global Market for Research Antibodies by Clonality
  • Global Market for Research Antibodies by Major Reactivities
  • Global Market for Research Antibodies by Host Species
  • Global Market for Research Antibodies by End User
  • Global Market for Research Antibodies by Region
  • Global Company Market Ranking Analysis

Chapter 11 Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150D)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports
  • Summary and Highlights
  • Industry Overview
  • Forces Driving Growth
  • Key Trends
  • Liquid Biopsy Initiatives
  • Global Market for Liquid Biopsy by Clinical Category
  • Global Market for Non-invasive Prenatal Testing
  • Global Market for Liquid Biopsy for Cancer Diagnostics
  • Global Market for Liquid Biopsy for Transplant Diagnostics
  • Global Market for Liquid Biopsy by Purpose of Analysis
  • Global Market for Liquid Biopsy by Biomarker Type
  • Global Market for Liquid Biopsy by Analysis Platform
  • Global Market for Liquid Biopsy by Geographic Region

Chapter 12 Induced Pluripotent Stem Cells: Global Markets (BIO135D)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Key Drivers for Market Growth
  • Technology Overview
  • Induced Pluripotent Stem Cell Generation
  • Induced Pluripotent Stem Cell Differentiation
  • Current Challenges to iPSC Applications
  • iPSCs Bank
  • Impact of COVID-19 on iPSCs
  • Pluripotent Stem Cells as a Study Model for COVID-19
  • Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
  • Market Overview
  • Market Breakdown by Region
  • Market Breakdown by Reprogramming Method
  • Market Breakdown by Application
  • Market Breakdown by Product
  • Induced Pluripotent Stem Cell-Derived Tissue Cell Market
  • Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
  • Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
  • Market for Induced Pluripotent Stem Cells by Product Function
  • Research Market Compared with the Clinical Market
  • Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
  • Induced Pluripotent Stem Cell Contract Service Types
  • Market Shares and Projections

Chapter 13 Cell Therapy Biomanufacturing: Global Markets (BIO211A)

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Related BCC Research Reports
  • Summary and Highlights
  • Market Breakdown by Application
  • Market Breakdown by Region
  • Market Trends & Challenges
  • Drivers
  • Restraints
  • Opportunity
  • Challenges

List of Tables

  • Table 1 : Global Market for Exosome Diagnostics and Therapeutics, by Application, Through 2026
  • Table 2 : Nomenclature of Exosome Particles
  • Table 3 : Publication Trend about Exosome, 2010-2020
  • Table 4 : Examples of Exosomal Proteins for Clinical Diagnostic Applications
  • Table 5 : Examples of Studies Using Extracellular Vesicles as Drug Delivery Vehicles
  • Table 6 : Examples of Engineering Exosome for Cargo Delivery
  • Table 7 : Global Market for Exosome Therapeutics and Diagnostics, by End User, Through 2026
  • Table 8 : Global Market for Exosome Diagnostics and Therapeutics, by Region, Through 2026
  • Table 9 : U.S. Patents on Exosome Diagnostics and Therapeutics, January 2015-September 2021
  • Table 10 : European Patents on Exosome Diagnostics and Therapeutics, January 2015-September 2021
  • Table 11 : Clinical Trials on Various Exosome Molecules
  • Table 12 : Global Market for Bioinformatics, by Application, Through 2025
  • Table 13 : Global Market for Sequencing Services and Platforms, Through 2025
  • Table 14 : Global Market for Bioinformatics, by Solution, Through 2025
  • Table 15 : Global Market for Bioinformatics, by End User, Through 2025
  • Table 16 : Global Market for Bioinformatics, by Region, Through 2025
  • Table 17 : North American Market for Bioinformatics, by Solution, Through 2025
  • Table 18 : North American Market for Sequencing Services and Platforms, Through 2025
  • Table 19 : North American Market for Bioinformatics, by Application, Through 2025
  • Table 20 : North American Market for Bioinformatics, by End User, Through 2025
  • Table 21 : North American Market for Bioinformatics, by Country, Through 2025
  • Table 22 : European Market for Bioinformatics, by Solution, Through 2025
  • Table 23 : European Market for Sequencing Services and Platforms, Through 2025
  • Table 24 : European Market for Bioinformatics, by Application, Through 2025
  • Table 25 : European Market for Bioinformatics, by End User, Through 2025
  • Table 26 : European Market for Bioinformatics, by Country, Through 2025
  • Table 27 : Asia-Pacific Market for Bioinformatics, by Solution, Through 2025
  • Table 28 : Asia-Pacific Market for Sequencing Services and Platforms, Through 2025
  • Table 29 : Asia-Pacific Market for Bioinformatics, by Application, Through 2025
  • Table 30 : Asia-Pacific Market for Bioinformatics, by End User, Through 2025
  • Table 31 : Asia-Pacific Market for Bioinformatics, by Country, Through 2025
  • Table 32 : Rest of the World Market for Bioinformatics, by Solution, Through 2025
  • Table 33 : Rest of the World Market for Sequencing Services and Platforms, Through 2025
  • Table 34 : Rest of the World Market for Bioinformatics, by Application, Through 2025
  • Table 35 : Rest of the World Market for Bioinformatics, by End User, Through 2025
  • Table 36 : Rest of the World Market for Bioinformatics, by Country, Through 2025
  • Table 37 : Bioinformatics Databases
  • Table 38 : Leading Drug Target Databases
  • Table 39 : Application of Cloud-Based Services in Healthcare
  • Table 40 : Leading LIMS Providers
  • Table 41 : Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
  • Table 42 : Leading EHR Providers, 2018
  • Table 43 : Medical Applications for Healthcare Professionals
  • Table 44 : Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2020
  • Table 45 : Global Market for Cell and Gene Therapy, by Therapy Type, Through 2026
  • Table 46 : Total Number of New Cases and Deaths Due to Various Cancers Globally, 2020
  • Table 47 : Comparison of Accelerated Approvals for Various Drugs
  • Table 48 : Global Market for Cell and Gene Therapy, by Product, Through 2026
  • Table 49 : Global Market for CGTs, by Application, Through 2026
  • Table 50 : Global Market for Cell and Gene Therapy, by Region, Through 2026
  • Table 51 : Total Number of Clinical Trials, by Indication, 2020
  • Table 52 : Key CGT Drug Candidates in Phase I Trials
  • Table 53 : Key CGT Drug Candidates in Phase II Trials
  • Table 54 : Key CGT Drug Candidates in Phase III Trials
  • Table 55 : CGT Drug Awaiting Approvals
  • Table 56 : Novartis Acquisitions and Collaborations Portfolio, 2018-2021
  • Table 57 : Gilead Acquisitions and Collaborations Portfolio
  • Table 58 : Global Market for Clinical Next-Generation Sequencing, by Disease Class, Through 2025
  • Table 59 : Scope of the Report
  • Table 60 : Global Market for Clinical NGS Testing, by Disease Type, Through 2025
  • Table 61 : Forces Influencing Growth in the Clinical NGS Testing Market
  • Table 62 : Key Trends in the Clinical NGS Testing Market
  • Table 63 : Clinical NGS Industry Subsectors
  • Table 64 : DNA Sequencing Historical Timeline
  • Table 65 : Sequencing Technology Development, 1990-2020
  • Table 66 : Cost of Sequencing a Single Human Genome, 2001-2021
  • Table 67 : Key Forces Driving Growth in Clinical NGS and Their Implications
  • Table 68 : Global Market for Clinical Sequencing, by Disease Category, Through 2025
  • Table 69 : Global Market for Clinical NGS in Oncology, by Indication, Through 2025
  • Table 70 : Global Market for Clinical NGS, by Test Complexity, Through 2025
  • Table 71 : Global Market for Clinical NGS, by Purpose of Test, Through 2025
  • Table 72 : Global Market for Clinical NGS, by Region, Through 2025
  • Table 73 : Global Market for Life Science Tools and Diagnostics, by Product Type, Through 2025
  • Table 74 : Distribution of COVID-19 Clinical Symptoms
  • Table 75 : Total Number of COVID-19 Confirmed Cases and Deaths Globally, by Region, Through Nov. 10, 2020
  • Table 76 : Global Market for Life Science Tools and Reagents, by End-User, Through 2025
  • Table 77 : Global Market for Life Science Tools and Diagnostics, by Region, Through 2025
  • Table 78 : North American Market for Life Science Tools and Diagnostics, by Country, Through 2025
  • Table 79 : European Market for Life Science Tools and Diagnostics, by Country, Through 2025
  • Table 80 : Asia-Pacific Market for Life Science Tools and Diagnostics, by Country, Through 2025
  • Table 81 : Global Market for DNA Sequencing, by Major Segment, Through 2026
  • Table 82 : Key Forces Driving Growth in Market for DNA Sequencing and Their Implications
  • Table 83 : Number of Sequencing Projects in GOLD Database, 2018-2020
  • Table 84 : Main Sequencing Applications
  • Table 85 : Genetic Testing Scope
  • Table 86 : Key Applications for Sequencing-Based Diagnostics
  • Table 87 : Global Market for DNA Sequencing, by Major Segment, Through 2026
  • Table 88 : Global Market for Sequencing Services, by End User, Through 2026
  • Table 89 : Global Market for Applied Sequencing Services, by Application, Through 2026
  • Table 90 : Global Market for Clinical Diagnostic Sequencing, by Disease Category, Through 2026
  • Table 91 : Global Market for Sample Preparation, by Product Type, Through 2026
  • Table 92 : Global Market for Sequencing Instruments and Consumables, by Product Type, Through 2026
  • Table 93 : Global Market for Sequencing Instruments and Consumables, by Product Generation, Through 2026
  • Table 94 : Global Market for DNA Sequencing, by Region, Through 2026
  • Table 95 : Global Market for mRNA Therapeutics, by Country/Region, Through 2026
  • Table 96 : Marketed/Commercial mRNA Vaccines, by Company
  • Table 97 : mRNA Drugs for Protein Therapy, Metabolic and Rare Diseases, by Company
  • Table 98 : Global Market for mRNA Therapeutics, by Product Segment, Through 2026
  • Table 99 : Global Market Shares of mRNA Therapeutics, by Therapeutic Application, 2026
  • Table 100 : Global Market for mRNA Therapeutics, by Disease Type, Through 2026
  • Table 101 : SWOT Analysis of the Market for mRNA Therapeutics
  • Table 102 : Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
  • Table 103 : Global Market for Cancer Stem Cells, by Region, Through 2026
  • Table 104 : North American Market for Cancer Stem Cells, by Country, Through 2026
  • Table 105 : North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
  • Table 106 : European Market for Cancer Stem Cells, by Country, Through 2026
  • Table 107 : European Market for Cancer Stem Cells, by Cancer Type, Through 2026
  • Table 108 : Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
  • Table 109 : Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
  • Table 110 : RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
  • Table 111 : RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
  • Table 112 : Global Market for Research Antibodies, by Application, Through 2025
  • Table 113 : Global Market for Research Antibodies, by Product, Through 2025
  • Table 114 : Global Market for Research Antibodies, by Clonality, Through 2025
  • Table 115 : Global Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 116 : Global Market for Research Antibodies, by Host Species, Through 2025
  • Table 117 : Global Market for Research Antibodies, by End User, Through 2025
  • Table 118 : Global Market for Research Antibodies, by Region, Through 2025
  • Table 119 : Global Market for Liquid Biopsy, by Disease Class, Through 2025
  • Table 120 : Forces Driving Growth in the Market for Liquid Biopsy
  • Table 121 : Key Trends in the Market for Liquid Biopsy
  • Table 122 : Liquid Biopsy-Related Research and Development Initiatives and Programs
  • Table 123 : Global Market for Liquid Biopsy, by Clinical Category, Through 2025
  • Table 124 : Global Market for NIPT, by Purpose of Analysis, Through 2025
  • Table 125 : Global Market for NIPT, by Risk Type, Through 2025
  • Table 126 : Global Market for NIPT Diagnostics, by Biomarker Class, Through 2025
  • Table 127 : Global Market for NIPT, by Analysis Method, Through 2025
  • Table 128 : Global Market for Liquid Biopsy for Cancer Diagnostics, by Cancer Site, Through 2025
  • Table 129 : Global Liquid Biopsy Cancer Market, by Purpose of Analysis, Through 2025
  • Table 130 : Global Market for Liquid Biopsy in Cancer Applications, by Biomarker Class, Through 2025
  • Table 131 : Global Market for Liquid Biopsy in Cancer Applications, by Analysis Method, Through 2025
  • Table 132 : Global Market for Liquid Biopsy in Transplant Applications, by Organ Type, Through 2025
  • Table 133 : Transplant Procedures Performed in the U.S., by Organ, 2018-2020
  • Table 134 : Global Market for Liquid Biopsy in Transplant Applications, by Purpose of Analysis, Through 2025
  • Table 135 : Global Market for Liquid Biopsy in Transplant Applications, by Biomarker Class, Through 2025
  • Table 136 : Global Market for Liquid Biopsy in Transplant Applications, by Analysis Method, Through 2025
  • Table 137 : Global Market for Liquid Biopsy, by Purpose of Analysis, Through 2025
  • Table 138 : Global Market for Liquid Biopsy, by Biomarker Type, Through 2025
  • Table 139 : FDA-Approved or CE-Marked Tests with Epigenetic Component
  • Table 140 : Global Market for Liquid Biopsy, by Analysis Platform, Through 2025
  • Table 141 : Global Market for Liquid Biopsy, by Region, Through 2025
  • Table 142 : Global Market for Liquid Biopsy in Cancer Applications, by Region, Through 2025
  • Table 143 : Global Market for Liquid Biopsy for NIPT, by Region, Through 2025
  • Table 144 : Global Market for Liquid Biopsy in Transplant Applications, by Region, Through 2025
  • Table 145 : Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
  • Table 146 : iPSCs Banks Worldwide, 2019
  • Table 147 : Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
  • Table 148 : U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2026
  • Table 149 : European Market for Induced Pluripotent Stem Cells, by Country, Through 2026
  • Table 150 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2026
  • Table 151 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2026
  • Table 152 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Method, Through 2026
  • Table 153 : Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 154 : U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 155 : European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 156 : Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 157 : Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 158 : Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2026
  • Table 159 : Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Species, Through 2026
  • Table 160 : Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2026
  • Table 161 : Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 162 : Global Market for Induced Pluripotent Stem Cells in Research and Clinical Uses, Through 2026
  • Table 163 : Major Commercial Suppliers of Induced Pluripotent Stem Cells Products, by Country
  • Table 164 : Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
  • Table 165 : Major Companies Providing iPSC Contract Services, by State/Country
  • Table 166 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Country/Region, Through 2026
  • Table 167 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
  • Table 168 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025

List of Figures

  • Figure 1 : Global Market for Exosome Diagnostics and Therapeutics, by Application, 2019-2026
  • Figure 2 : Publication Trends for Exosomes, 2010-2020
  • Figure 3 : U.S. Patent Documents by Published, Filed and Granted Dates, 2015-2021
  • Figure 4 : European Patent Documents by Published, Filed and Granted Dates, 2015-2021
  • Figure 5 : Global Market Shares of Bioinformatics, by Application, 2019
  • Figure 6 : Collaboration within the Bioinformatics Arena, by Country, Since 2016
  • Figure 7 : Number of Drug Approvals, by FDA's CDER, 2008-2020
  • Figure 8 : Number of CDER's Annual Novel Drug Approvals, 2009-2019
  • Figure 9 : Global Market Shares of Sequencing Services and Platforms, 2019
  • Figure 10 : Global Market Shares of Bioinformatics, by Solution, 2019
  • Figure 11 : Global Market Shares of Bioinformatics, by End User, 2019
  • Figure 12 : Global Market Shares of Bioinformatics, by Region, 2019
  • Figure 13 : Phases in the Drug Discovery and Development Process
  • Figure 14 : Application of Bioinformatics in Clinical Trials
  • Figure 15 : Global Market for Cell and Gene Therapy, by Therapy Type, 2019-2026
  • Figure 16 : Total Number of Clinical Trials, by Phase, 2020
  • Figure 17 : Global Market for Clinical Next-Generation Sequencing, by Disease Class, 2019-2025
  • Figure 18 : Global Market for Life Science Tools and Diagnostics, by Product Type, 2018-2025
  • Figure 19 : Global Market Shares of Life Science Tools and Diagnostics, by Region, 2019
  • Figure 20 : RoW Market for Life Science Tools and Diagnostics, 2018-2025
  • Figure 21 : Global Market for DNA Sequencing, by Major Segment, 2020-2026
  • Figure 22 : Global Market for mRNA Therapeutics, by Country/Region, 2020-2026
  • Figure 23 : Global Market for mRNA Therapeutics, by Product Segment, 2020-2026
  • Figure 24 : Global Market for mRNA Therapeutics, by Disease Type, 2020-2026
  • Figure 25 : Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
  • Figure 26 : Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
  • Figure 27 : Incidence of Cancer, 2020
  • Figure 28 : Mortality of Cancer, 2020
  • Figure 29 : Major Issue in Stem Cell Research in Iran, 2017
  • Figure 30 : Global Market Shares of Cancer Stem Cells, by Region, 2020
  • Figure 31 : North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
  • Figure 32 : European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
  • Figure 33 : Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
  • Figure 34 : RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
  • Figure 35 : Global Market Shares for Research Antibodies, by Application, 2019
  • Figure 36 : Global Market Shares for Research Antibodies, by Product, 2019
  • Figure 37 : Global Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 38 : Global Market Shares for Research Antibodies, by Major Reactivities, 2019
  • Figure 39 : Global Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 40 : Global Market Shares for Research Antibodies, by End User, 2019
  • Figure 41 : Global Market Shares for Research Antibodies, by Region, 2019
  • Figure 42 : Global Market Ranking of Research Antibodies, by Manufacturer, 2019
  • Figure 43 : Global Market for Liquid Biopsy, by Disease Class, 2019-2025
  • Figure 44 : Global Market for Induced Pluripotent Stem Cells, by Country/Region, 2020-2026
  • Figure 45 : Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020
  • Figure 46 : Global Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 47 : U.S. Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 48 : European Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 49 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 50 : Rest of the World Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 51 : Global Market Shares of Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2020
  • Figure 52 : Global Market Shares of Induced Pluripotent Stem Cell-Derived Cells, by Application, 2020
  • Figure 53 : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
  • Figure 54 : Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
  • Figure 55 : Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025